GCSAM
Germinal center-associated signaling and motility protein
Also known as: GCET2, GCSAM_HUMAN, HGAL, MGC40441
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N6F7
- Gene
- GCSAM
- Ensembl
- ENSG00000174500
- Chromosome
- 3
- Canonical length
- 178 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a protein which may function in signal transduction pathways and whose expression is elevated in germinal cell lymphomas. It contains a putative PDZ-interacting domain, an immunoreceptor tyrosine-based activation motif (ITAM), and two putative SH2 binding sites. In B cells, its expression is specifically induced by interleukin-4. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
178 residues, UniProt reviewed canonical sequence.
>Q8N6F7|GCSAM
1 MGNSLLRENR RQQNTQEMPW NVRMQSPKQR TSRCWDHHIA EGCFCLPWKK ILIFEKRQDS
61 QNENERMSST PIQDNVDQTY SEELCYTLIN HRVLCTRPSG NSAEEYYENV PCKAERPRES
121 LGGTETEYSL LHMPSTDPRH ARSPEDEYEL LMPHRISSHF LQQPRPLMAP SETQFSHLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GCSAM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.7
- Highest tissue expression
- 27 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 27 nTPM
- lymph node: 21 nTPM
- thymus: 17 nTPM
- skin: 16 nTPM
- appendix: 6.1 nTPM
- spleen: 4.7 nTPM
Single-cell type
- renal collecting duct principal cells: 3.3 nCPM
- cdc: 2.1 nCPM
- pdcs: 1.9 nCPM
- t-cells: 1.2 nCPM
- b-cells: 1 nCPM
- kupffer cells: 1 nCPM
Immune cell
- naive B-cell: 12 nTPM
- memory CD4 T-cell: 11 nTPM
- naive CD4 T-cell: 10 nTPM
- memory B-cell: 10 nTPM
- basophil: 9 nTPM
- myeloid DC: 6.7 nTPM
Brain region
- choroid plexus: 1 nTPM
- cerebral cortex: 0.7 nTPM
- midbrain: 0.7 nTPM
- basal ganglia: 0.6 nTPM
- hypothalamus: 0.6 nTPM
- thalamus: 0.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1
- gnomAD pLI
- 0.06
- gnomAD missense Z
- 0.49
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GCSAM in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GCSAM as an antibody target. Whether an autoantibody or antibody against GCSAM could matter depends on whether native GCSAM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GCSAM is annotated at the cell surface, where native GCSAM is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GCSAM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...